跳至主要内容
临床试验/NCT06542380
NCT06542380已完成不适用

TAVI PACER: A Two-step Risk Score for Prediction of Permanent Pacemaker Implantation After TAVI.

German Heart Institute1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2022年2月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,000
试验地点
1
主要终点
Pacemaker Implantation

研究概览

简要总结

The need for permanent pacemaker implantation (PPMI) remains one of the most frequent complications after transcatheter aortic valve implantation (TAVI). This study aimed to develop a novel, two-step risk score to predict PPMI probability after TAVI and to implement it into a user-friendly website. Our risk score addresses the gap in existing data on current prosthesis generations and provides a new and clinically motivated approach to calculating the risk for PPMI.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
51 Years 至 95 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing TAVI at Deutsches Herzzentrum der Charité between January 2019 and December 2020

排除标准

  • previous device implantation
  • valve-in-valve procedure
  • patients who had received an ALLEGRATM valve (NVT AG, Morges, Switzerland), a LOTUS EdgeTM valve (Boston, Scientific, Natick, Massachusetts), or a CENTERATM valve (Edwards Lifesciences, Irvine, California)

结局指标

主要结局

Pacemaker Implantation

时间窗: 30 days after TAVI

Rate of pacemaker implantation up to 30 days after TAVI according to current guidelines

次要结局

未报告次要终点

研究者

发起方
German Heart Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Julia Lueg

Principal Investigator

German Heart Institute

研究点 (1)

Loading locations...

相似试验

TAVI PACER: A Two-step Risk Score for Prediction of... | 临床试验